Akèy › Dyabèt Tip 2 › Massachusetts › Boston
Etid klinik pou Dyabèt Tip 2 nan Boston, MA
20 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Ap rekriteVolontè an sante akeyi
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Ap rekriteFaz 2
- Brigham & Women's Hospital, Boston
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Ap rekriteFaz 3
- Brigham & Women's Hospital, Boston
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Boston
- Research Site, Boston
Vitamin D and Type 2 Diabetes - Treat-To-Target
Ap rekriteFaz 3
- Tufts Medical Center, Boston
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Ap rekrite
- Joslin Diabetes Center, Boston
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Ap rekrite
- Joslin Diabetes Center, Boston
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
Ap rekriteFaz 4Volontè an sante akeyi
- Massachusetts General Hospital, Boston
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Ap rekrite
- Brigham and Women's Hospital, Boston
EVOC - EVs in Obesity and Cardiometabolic Disease
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital, Boston
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Ap rekrite
- Massachusetts General Hospital, Boston
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
Ap rekrite
- Joslin Diabetes Center, Boston
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Ap rekriteEtid obsèvasyon
- Boston Children's/Joslin Diabetes Center/Massachusetts General Hospital, Boston
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Ap rekriteVolontè an sante akeyi
- President and Fellows of Harvard College, T.H. Chan School, Boston
NAD Augmentation in Diabetes Kidney Disease
Ap rekriteFaz 2
- Brigham and Women's Hospital, Boston
Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes
Ap rekrite
- Massachusetts General Hospital, Boston
Diabetes Body Project 2
Ap rekrite
- Joslin Diabetes Center, Boston
Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
Ap rekrite
- Boston Medical Center, Boston
Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital, Boston
RESET System Pivotal Trial (Rev F)
Ap rekrite
- Brigham and Women's Hospital, Boston
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL24 etid
- Miami, FL19 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- Atlanta, GA17 etid
- San Diego, CA17 etid
- Los Angeles, CA16 etid
- New York City, NY16 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.